Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo

European Journal of Immunology
Clarissa Prazeres da CostaThomas Miethke

Abstract

Heat shock protein 60 (HSP60) from Chlamydia pneumoniae was described to trigger in vitro inflammatory and cytokine responses including TNF and IL-12p40. Although it can be found in atherosclerotic plaques of patients, the stimulatory potential of chlamydial and other HSP60 in vivo is unclear. We now report that chlamydial HSP60 fails to induce TNF expression in vivo, and significant serum levels of IL-12p40 are only found upon intraperitoneal injection of high doses of HSP60 or after intravenous application. Upon purification of chlamydial HSP60 with polymyxin B-agarose columns, its ability to induce TNF secretion in vitro is much reduced. However, purified chlamydial HSP60 causes increased serum levels of the CXC chemokines KC and MIP2 in vivo, as well as a strong accumulation of polymorphonuclear neutrophils (PMN) in the peritoneal cavity upon intraperitoneal challenge. With respect to PMN accumulation, chlamydial HSP60 is more potent than endotoxin or the CpG oligonucleotide 1668. The responses observed are completely abolished in Toll-like receptor (TLR)2/4-double-deficient mice, while single-deficient mice respond almost normally. Furthermore, KC induction and PMN accumulation are largely dependent on MyD88. In conclusion...Continue Reading

Citations

Aug 6, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Rajneesh JhaAruna Mittal
Dec 4, 2010·Zeitschrift für Rheumatologie·M Rihl, J G Kuipers
Jun 2, 2005·Nature Reviews. Immunology·John R Rodgers, Richard G Cook
Jun 23, 2006·Infection and Immunity·Brian HendersonAnthony R M Coates
Feb 20, 2008·PLoS Pathogens·Matthew D DyerBruno W Sobral
Jul 7, 2011·Reproduction : the Official Journal of the Society for the Study of Fertility·J P Mackern ObertiV E Rivero
Jul 24, 2010·Mediators of Inflammation·Jennifer E ColeClaudia Monaco
Jan 7, 2015·International Journal of Molecular Sciences·Marisa Di PietroRosa Sessa
Nov 28, 2006·Best Practice & Research. Clinical Rheumatology·Markus RihlJens G Kuipers
Jul 18, 2006·Oral Microbiology and Immunology·J G M ArguetaS Hanazawa
Apr 5, 2013·Biological Reviews of the Cambridge Philosophical Society·Brian HendersonPeter A Lund
Nov 14, 2013·Clinical Science·Steven O'Reilly
Jan 6, 2011·FEMS Immunology and Medical Microbiology·Brigida Rusconi, Gilbert Greub
Apr 8, 2015·PLoS Neglected Tropical Diseases·Vijayan KamalakannanRangarajan Badri Narayanan
Jun 13, 2006·Immunology Letters·Sonia J WakelinSarah E M Howie
Oct 5, 2007·Microbes and Infection·Takatoshi KitazawaYasuo Ota
Nov 1, 2016·International Journal of Inflammation·Mohsin H K RoshanNikolai P Pace
Dec 18, 2007·Current Opinion in Immunology·Maureen McMahon, Bevra H Hahn
Oct 20, 2006·Vaccine·Khaleda Rahman QaziCarmen Fernández
Oct 25, 2007·Journal of Endotoxin Research·Corinna Hermann
Jul 11, 2007·Journal of Endotoxin Research·Min-Fu Tsan, Baochong Gao
Jun 6, 2008·Virchows Archiv : an International Journal of Pathology·Yuri V BobryshevReginald Lord
Jul 27, 2010·Fundamental & Clinical Pharmacology·Justin F Deniset, Grant N Pierce
Sep 22, 2012·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D S FerreiraT Mauad
Nov 26, 2010·Expert Review of Cardiovascular Therapy·Jennifer E ColeClaudia Monaco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.